| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.
Over the last 12 months, insiders at Bone Biologics Corporation have bought $0 and sold $0 worth of Bone Biologics Corporation stock.
On average, over the past 5 years, insiders at Bone Biologics Corporation have bought $21,637 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,000 shares for transaction amount of $5,120 was made by Walsh Deina H (Chief Financial Officer) on 2023‑09‑13.
| 2023-09-13 | Walsh Deina H | Chief Financial Officer | 8,000 0.2552% | $0.64 | $5,120 | -55.66% | ||
| 2023-09-11 | Frelick Jeff | Chief Executive Officer | 9,500 0.311% | $0.69 | $6,530 | -55.50% | ||
| 2023-09-06 | Walsh Deina H | Chief Financial Officer | 7,000 0.219% | $0.71 | $4,967 | -58.20% | ||
| 2023-08-31 | Frelick Jeff | Chief Executive Officer | 7,600 0.2366% | $0.66 | $5,020 | -54.06% | ||
| 2020-01-02 | Hankey Don | Chairman of the Board | 195,000 1.6745% | $1.00 | $195,000 | +238663.11% | ||
| 2020-01-02 | Hankey Bret | director | 195,000 1.6745% | $1.00 | $195,000 | +238663.11% | ||
| 2019-08-06 | Hankey Don | Chairman of the Board | 553,191 – | $0 | $0 | |||
| 2019-08-06 | Hankey Bret | director | 553,191 – | $0 | $0 | |||
| 2019-07-15 | Hankey Don | Chairman of the Board | 85,106 – | $0 | $0 | |||
| 2019-07-15 | Hankey Bret | director | 85,106 – | $0 | $0 | |||
| 2019-06-20 | Hankey Bret | director | 1.06M – | $0 | $0 | |||
| 2019-06-20 | Hankey Don | Chairman of the Board | 1.06M – | $0 | $0 | |||
| 2019-05-07 | Hankey Don | Chairman of the Board | 1.06M – | $0 | $0 | |||
| 2019-05-07 | Hankey Bret | director | 1.06M – | $0 | $0 | |||
| 2019-03-25 | Hankey Don | Chairman of the Board | 1.49M – | $0 | $0 | |||
| 2019-03-25 | Hankey Bret | director | 1.49M – | $0 | $0 | |||
| 2018-12-17 | Hankey Don | Chairman of the Board | 18.01M – | $0 | $0 | |||
| 2018-12-17 | Hankey Bret | director | 18.01M – | $0 | $0 | |||
| 2016-02-29 | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | 10 percent owner | 731,707 23.9735% | $2.05 | $1.5M | |||
| 2015-12-22 | Sale | SOO B CHIA | director | 5,274 0.1332% | $1.58 | $8,333 |
| Hankey Don | Chairman of the Board | 28563398 1591.0451% | $50.84M | 7 | 0 | |
| Hankey Bret | director | 28122518 1566.4871% | $50.06M | 7 | 0 | |
| MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | 10 percent owner | 11640096 648.3794% | $20.72M | 1 | 1 | |
| AFH Holding & Advisory, LLC | 10 percent owner | 3385358 188.572% | $6.03M | 0 | 3 | |
| SOO B CHIA | director | 2982804 166.1488% | $5.31M | 0 | 2 | |
| WU BENJAMIN | director | 970991 54.0864% | $1.73M | 0 | 2 | |
| Frelick Jeff | Chief Executive Officer | 17204 0.9583% | $30,623.12 | 2 | 0 | <0.0001% |
| Walsh Deina H | Chief Financial Officer | 15000 0.8355% | $26,700.00 | 2 | 0 | <0.0001% |
$1,105,104 | 34 | -11.40% | $435.81M | |
$58,432,429 | 19 | 7.16% | $173.21M | |
$5,181,911 | 18 | -5.82% | $75.03M | |
$165,149 | 7 | -44.78% | $12.62M | |
$170,016 | 6 | 9.19% | $182.53M | |
$24,971 | 6 | -37.72% | $47.87M | |
$12,684,208 | 6 | 17.63% | $14.3M | |
$6,864 | 5 | 59.01% | $12.87M | |
$330,888 | 5 | 7.30% | $197,541.00 | |
Bone Biologics Corporation (BBLG) | $21,637 | 4 | -55.86% | $3.2M |
$13,650 | 1 | -48.97% | $8.55M | |
$19,977 | 1 | 10.97% | $284.3M | |
$2,000,000 | 1 | -13.69% | $1.15B |
| Increased Positions | 7 | +350% | 13,013 | +4,105.05% |
| Decreased Positions | <1 | -50% | 47 | -14.83% |
| New Positions | 5 | New | 11,739 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 8 | +300% | 13,283 | +4,090.22% |
| Drw Securities, Llc | $17.00 | 0.55% | 11,027 | +11,027 | New | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $2.00 | 0.07% | 1,464 | +1,264 | +632% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $0 | 0.01% | 230 | +230 | New | 2025-09-30 |
| Citigroup Inc | $0 | 0.01% | 206 | +206 | New | 2025-09-30 |
| Clear Street Llc | $0 | 0.01% | 138 | +138 | New | 2025-06-30 |
| Clear Street Group Inc. | $0 | 0.01% | 138 | +138 | New | 2025-09-30 |
| Ubs Group Ag | $0 | <0.01% | 66 | -47 | -41.59% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 14 | +10 | +250% | 2025-09-30 |